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razil. Bacterial genomic DNA from breast milk was puri-
ed from breast milk samples and quantitative PCR assays
ere designed to measure the amounts of Staphylococcus,
actobacilli and total bacteria. Primers for Staphylococcus
ureus assays were based on the Staphylococcus aureus spe-
iﬁc nuc gene, while Lactobacilli speciﬁc 16S ribosomal gene
egions were used to design primers speciﬁc to Lactobacillus
enus. Total bacteria were determined in quantitative PCR
ssays using universal bacterial primers based on conserved
egions of the 16S ribosomal gene.
Results: Preliminary quantitative PCR results of 24 sam-
les indicate that Staphylococcus aureus was present in
oughly 47% (n = 11) of milk and Lactobacilli was present
n 82% (n = 19) of milk samples. Lactobacilli levels varied
etween 70—103 copies/ul while Staphylococcus aureus lev-
ls were higher (102—106 copies/ul).
Conclusion:Our results suggest that Lactobacilli aremore
ommon in breast milk than previously reported in liter-
ture. We will investigate whether Lactobacilli levels in
reast milk are related to Staphylococcus aureus levels in
ealthy and mastitis milk. If the levels of commensal Lac-
obacilli and pathogenic Staphylococcus aureus are related,
his suggests that microbial milk composition is an impor-
ant determinant of breast milk health and indicates the
eed to investigate whether probiotic supplementation with
actobacilli can help reduce the risk of mastitis in women.
oi:10.1016/j.ijid.2010.02.504
7.029
treptococcus pneumoniae treatment with cate-
holamines affects growth based on strain isolation
ite with a lack of effect on bioﬁlm formation
.F. Gonzales1,∗, F. Quinones Falconi2, G. Castillo Rojas1, Y.
opez Vidal1
Universidad Nacional Autonoma de Mexico, Mexico, Mexico
National Institute of Respiratory Diseases, Mexico, Mexico
Background: It is known that bacterial physiological
esponses are affected by catecholamines (norepinephrine,
pinephrine) in vitro. Considering that catecholamines par-
icipate in stimulating growth in bacteria such as E. coli and
evelopment of bioﬁlms with Salmonella. Along with obser-
ations of the effect of catecholamines on oral Streptococcal
pecies, not including Streptococcus pneumoniae, revealing
varied affect on growth and bioﬁlm formation between
pecies. S. pneumoniae is the most common cause of bacte-
ial pneumonia worldwide and is known to develop bioﬁlms
n otits media infections. We aim to determine if nore-
inephrine stimulates S. pneumoniae growth and bioﬁlm
ormation in vitro, and if the clinical isolation history of
he bacteria is a factor in this response. The gathered data
ill provide information on catecholamine participation on
athogenesis.
Methods: Four clinical strains of S. pneumoniae of which
wo were isolated from nasal swabs and two from blood
amples were cultured in Todd Hewitt broth with yeast
xtract; treated culture included 10—4M of norepinephrine
r epinephrine. Bioﬁlm experiments utilized cellculture
icrotiter plates in which control and treated bacteria were
dded to respective wells and incubated for 24 hrs. Changes
b
c
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n growth and bioﬁlm formation were determined by mea-
urement of optical density.
Results: The data revealed a 4 to 6 fold increase in growth
n catecholamine treated S. pneumoniae collected from
lood samples, while a 3 to 4 fold increase in nasal swab sam-
les as compared to non treated cultures. Catecholamine
reatment of S. pneumoniae revealed no signiﬁcant differ-
nce in the formation of bioﬁlms.
Conclusion: The results demonstrate that S. pneumoniae
xposed to catecholamines increases growth which could
llow for increased colonization of the bacteria in the res-
iratory tract thereby increasing the chances of infection.
he difference in the magnitude of fold increase in blood
amples versus nasal swab samples could indicate that cul-
ures vary there responses to catecholamines as infection
nhances. Bioﬁlm data shows that there is no signiﬁcant
ifference in bioﬁlm formation 24hrs post treatment ver-
us control indicating that catecholamines have no affect
n stimulating bioﬁlms in S. pneumoniae in vitro.
oi:10.1016/j.ijid.2010.02.505
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hronic pain: Crucial symptom in a case of neuroborrelio-
is analysis of three cases
. Marcinkowska1,∗, A. Horban1, M. Malec-Milewska2
Hospital of Infectious Dieseases, Warsaw, Poland
Anaesthesiology and Intensive Care the Medical of Post-
raduate Education, Warsaw, Poland
Background: Neuroborreliosis is a one of the form of Lyme
isease, which involving nervous system. The symptomatol-
gy results from disease’s localization in any part of nervous
ystem.
Methods: Retrospective review of the patients from pain
utpatient Clinic, with untreatable, chronic pain.
Results: Case 1: A 41 years old woman presented with
ain and sense disturbances of superior and inferior extrem-
ties. The pain intensiﬁcation was estimated in 6 points,
umerical rating score (NRS). The patient denied tick bite
nd erythema migrans (EM). Physical examination showed
ense abnormalities corresponding to patient’s complaints.
MG showed the signs of peripheral neuronal damage involv-
ng both motor and sensory ﬁbers. Analgesic treatment
as ineffective. The antibodies against Borrelia burgdorferi
B.b.) were detected in serum, conﬁrmed by Western blot
ssay (W.b.). Polineuropathy in course of neuroborreliosis
as diagnosed.
Case2: A 55 years old woman after surgery for chondroﬁ-
roma of vertebral canal, reported severe pain involving
he whole length of spine, with bilateral radiation to inter-
ostals spaces and pelvis, accompanied by muscle and joint
ain. Pain intensity was 10 points according to NCS. She
id not notice tick bite, but EM was recognized. Analgesic
reatment was ineffective. MRI studies showed low grade
iscopathy which did not explain patient complaints. The
ntibodies against B.b. were detected in serum, conﬁrmed
y W.b.assay. CSF examination showed a lymphocytic pleo-
ytosis, a moderately elevated protein level. Antibodies
gainst B.b. were found in CSF.
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Generalized borreliosis with CNS and joints involvement
was diagnosed.
Case 3: A 31 years old woman presented severe pain
NCS=8 points in anterior femoral region. No tick bite was
noticed. EM was recognized. Analgesic treatment did not
cause any alleviation of pain. Physical examination showed
skin paresthesia corresponding to region of pain. The anti-
bodies against B.b. were detected in serum, conﬁrmed by
W.b. assay. Femoral nerve radiculopathy in course of neu-
roborreliosis was diagnosed. All patients were treated with
antibiotics: ceftriaxone.
Conclusion: In cases, when pathomechanism of pain is
difﬁcult to understand, neuroborreliosis should be included
as one of differential diagnosis. The real diagnosis and
treatment result in complete withdrawal of pain and other
clinical symptoms.
doi:10.1016/j.ijid.2010.02.506
HIV: Opportunistic Infections & Malignancies (Poster
Presentation)
78.001
The emerging of non-AIDS related neoplasms in the era of
combined antiretroviral therapy
R. Manfredi
University of Bologna, Bologna, Italy
Background: The introduction of combined antiretroviral
therapy (cART) since the year 1996, contributed to a rapid,
signiﬁcant drop of frequency of all AIDS-deﬁning opportunis-
tic infections and some selected AIDS-related tumors (like
Kaposi’sarcoma), with a consequent, remarkable reduction
of both morbidity and mortality rates associated with these
disease complications.
Methods: Our cohort of over 1,700 HIV-infected patients
followed in two connected outpatient centres by the
same physician staff were prospectively followed since
the year 2000 (9 years), with special interest focused on
the diagnosis, treatment and outcome of non-AIDS related
malignancies.
Results: Among hematological malignancies other than
non-Hodgkin’s lymphoma and primary central nervous
system lymphoma, we observed three cases of acute myel-
ogenic leukaemia and 4 episodes of Hodgkin’s lymphoma. A
greater number of solid tumors involved different organs
and sites: laryngeal cancer (8 cases, with 6 episodes of
papillomatous laryngeal cancer), rhinopharyngeal squamous
carcinoma (4 cases), adenocarcinoma of the lung (6 cases),
gastric adenocarcinoma (3 episodes), esophageal carcinoma
(2 patients), prostate cancer (4 cases), bladder adnocar-
cinoma (3 episodes) pancreatic adenocarcinoma (2 cases),
and squamos anal carcinoma (2 episodes). Some of these
malignancies have been reported with extremely rare fre-
quency until now (usually as single-case anecdotal reports),
in particular before the cART era. The patient’s age ranged
from 34 to 67 years, the mortality rate of these episodes
was very elevated (over 80%), and occurred 3-41 months
after diagnosis, despite appropriate surgical and/or cyto-
toxic chemotherapy and/or radiotherapy.
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Conclusion: The signiﬁcantly increased life expectancy
f HIV infected patients in the cART era was charac-
erized by a proportionally increase of non-AIDS-deﬁning
umors, which may depend on the advanced mean patients’
ge, their prolonged exposure to risk factor, the persist-
ng functional immune system imbalance, and probably
ome direct oncogenic property of HIV itself, even when
‘‘quantitative’’ recovery of CD4+ lymphocyte count has
een achieved thanks to cART. The differential diagnosis
f non-AIDS-associated tumors may be delayed by the low
linical suspicion, and their frequency to mimick and/or
verlap infectious complications. Further epidemiological
nd clinical investigation is strongly warranted, to increase
he awareness of this emerging phenomenon.
oi:10.1016/j.ijid.2010.02.507
8.002
he role of the tuberculosis in outcome and treatment
ailure in HIV-infected Cambodian children
. Krcmery ∗, B. Irad, J. Vujcikova, E. Mitterpachova, A.
alavska, P. Kisac
St. Elizabeth University College of Health and Social Sci-
nces, Bratislava, Slovakia
Background: Tuberculosis and AIDS are considered to be a
‘deadly synergy’’ among HIVinfected children in Southeast
sia and sub-Saharan Africa.
Methods: We have assessed a cohort of 118 HIV-infected
hildren, 72 of them receive antiretroviral therapy (HAART)
or an average of 38 months (12-63 months), for the preva-
ence of tuberculosis, anti-tuberculosis therapy, immune
esponse to HAART and coincidence of other opportunistic
nfections. Table 1 shows a cohort of 40 HIV-infected chil-
ren with tuberculosis (36 pulmonary and 4 extrapulmonary)
ompared to 32 HIV — infected children without tuberculosis
ut with AIDS and other opportunistic infections.
Results: Children with tuberculosis were signiﬁcantly
ounger (P<0.01) (7.8 vs. 12.8 years) and had signiﬁcantly
ower CD4 absolute count (180 vs. 302) in comparison to
IV-infected children without tuberculosis. Immune cate-
ory 3 (82.5% vs. 59,4%, P<0.05) and CDC category C (45% vs.
.4%, P<0.001) were also more frequently observed among
IV-infected children with tuberculosis.
Proportion of deaths (3 children within 5 years within
2 children on HAART) or treatment failure on 1-st line
AART (6 children) was similar in both groups of children
with tuberculosis and without tuberculosis). Frequency of
pportunistic infections (more than 5 per year) among tuber-
ulosis children cohort was also higher among tuberculosis
IV-infected children (70% vs. 21,9%, P<0.001). Otitis media
55% vs. 31,1% P<0.05), oropharyngeal candidiasis (45% vs.
1,9% P<0.04), Immune reconstruction syndrome (IRS) (40%
s. 12,5%, P<0.001) occurred signiﬁcantly more frequently
n HIV-infected children with tuberculosis in comparison to
hildren without tuberculosis. Anti tuberculosis treatment
Isoniazide + Rifampin + Pyrazinamid) was given 4-8 weeks
efore onset of HAART (lamivudine + didanosin + efavirens),
o decrease the probability of IRS. Most children received 6
onths treatment with Isoniazide + Rifampin + Pyrazinamid
60%) or Ethambutol (40% children older than 10 years), 7-9
